DK0876817T3 - Lægemiddel til keratoconjunctivistiske sygdomme - Google Patents

Lægemiddel til keratoconjunctivistiske sygdomme

Info

Publication number
DK0876817T3
DK0876817T3 DK97900439T DK97900439T DK0876817T3 DK 0876817 T3 DK0876817 T3 DK 0876817T3 DK 97900439 T DK97900439 T DK 97900439T DK 97900439 T DK97900439 T DK 97900439T DK 0876817 T3 DK0876817 T3 DK 0876817T3
Authority
DK
Denmark
Prior art keywords
keratoconjunctivist
diseases
drug
gefarnate
corneal
Prior art date
Application number
DK97900439T
Other languages
English (en)
Inventor
Katsuhiko Nakata
Masatsugu Nakamura
Takashi Hamano
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK0876817T3 publication Critical patent/DK0876817T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK97900439T 1996-01-22 1997-01-17 Lægemiddel til keratoconjunctivistiske sygdomme DK0876817T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP08008243A JP3136352B2 (ja) 1996-01-22 1996-01-22 角結膜疾患治療剤

Publications (1)

Publication Number Publication Date
DK0876817T3 true DK0876817T3 (da) 2004-10-11

Family

ID=11687714

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97900439T DK0876817T3 (da) 1996-01-22 1997-01-17 Lægemiddel til keratoconjunctivistiske sygdomme

Country Status (11)

Country Link
US (1) US6040343A (da)
EP (1) EP0876817B1 (da)
JP (1) JP3136352B2 (da)
KR (1) KR100427115B1 (da)
CN (1) CN1203849C (da)
AT (1) ATE270101T1 (da)
DE (1) DE69729721T2 (da)
DK (1) DK0876817T3 (da)
ES (1) ES2221030T3 (da)
PT (1) PT876817E (da)
WO (1) WO1997026872A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040014812A1 (en) * 2000-11-08 2004-01-22 Santen Pharmaceutical Co. Ltd Remedies for keratoconjunctival diseases containing farnesyl acetate as the active ingredient
JP4778262B2 (ja) * 2005-04-27 2011-09-21 テイカ製薬株式会社 角膜疾患治療剤
CN101312962A (zh) * 2005-12-06 2008-11-26 参天制药株式会社 角膜结膜病变的治疗剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
WO1992003122A1 (de) * 1990-08-24 1992-03-05 Gregor Cevc Präparat zur wirkstoffapplikation in kleinsttröpfchenform
JP2855307B2 (ja) * 1992-02-05 1999-02-10 生化学工業株式会社 光反応性グリコサミノグリカン、架橋グリコサミノグリカン及びそれらの製造方法
JPH06192073A (ja) * 1992-12-24 1994-07-12 Eisai Co Ltd 細胞分化誘導剤

Also Published As

Publication number Publication date
CN1209743A (zh) 1999-03-03
CN1203849C (zh) 2005-06-01
ATE270101T1 (de) 2004-07-15
EP0876817A4 (en) 2003-07-02
DE69729721D1 (de) 2004-08-05
KR100427115B1 (ko) 2004-08-06
EP0876817B1 (en) 2004-06-30
KR19990081836A (ko) 1999-11-15
DE69729721T2 (de) 2005-08-04
WO1997026872A1 (en) 1997-07-31
JP3136352B2 (ja) 2001-02-19
ES2221030T3 (es) 2004-12-16
PT876817E (pt) 2004-10-29
EP0876817A1 (en) 1998-11-11
JPH09194363A (ja) 1997-07-29
US6040343A (en) 2000-03-21

Similar Documents

Publication Publication Date Title
FI963424A0 (fi) Menetelmä terapeuttisesti aktiivisten tiofeenisulfonamidien valmistamiseksi
NO893021D0 (no) Fremgangsmaate for fremstilling av en biologisk aktiv forbindelse, fr 901228.
CA2396561A1 (en) Substituted oxazolidinones and their use in the field of blood coagulation
NO975962D0 (no) Legemiddelpreparat som omfatter albumin som aktiv bestanddel
HUT47977A (en) Polipeptides, process for their production and process for production of medical compositions containing such active substances
ATE286880T2 (de) Verwendung von fluprostenolisopropylester zur herstellung eines arzneimittels zur behandlung von glaukom und okularer hypertension
TNSN89019A1 (fr) 4-(4-phenyl-1-piperazinyl) phenols utiles comme medicamments notamment pour inhiber la 5-lipoxygenase, nouveaux composes de ce type et procedes pour leur preparation
DE69317494D1 (de) Zusammensetzungen, die mono oder polyhydroxylierte Aminosäuren zur Behandlung des Insulinunabhängigen Diabetes Mellitus enthalten
PT88985A (pt) Processo para a preparacao de composicoes farmaceuticas nasais e ou oftalmicas contendo azelastina
ATE184193T1 (de) Verwendung von n-acylaminoalkoholen zur herstellung eines arzneimittels zur behandlung von mastzellerkrankungen
ATE179888T1 (de) Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure
ATE68182T1 (de) Thiophensulfonamide zur behandlung von glaukom.
EP0179430A3 (en) Aqueous pharmaceutical formulations of piroxicam monohydrate
FR2614618B1 (fr) Derives heterocycliques polycycliques, leur procede de preparation et leur utilisation en medecine humaine et veterinaire
CA2005987A1 (en) Therapeutically active substituted benzimidazole and process for its preparation
DE68904462D1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten.
ATE123945T1 (de) Verwendung von fluor enthaltenden pyridoncarbonsäure-derivaten zur herstellung eines arzneimittels zur behandlung von hiv infektionen.
DE59102701D1 (de) Arzneimittelzubereitung zur systemischen Behandlung von Zier- und Nutzfischen.
DK0876817T3 (da) Lægemiddel til keratoconjunctivistiske sygdomme
ATE216889T1 (de) Anwendung von prostagrandin-analogen für die behandlung von glaukome und okuläre hypertension
JPS5592305A (en) White cosmetic
ATE152350T1 (de) Pharmazeutische zusammensetzungen die 5- difluormethoxy-2-(3,4-dimethoxy-2- pyridyl)methylsulfinyl>-1h-benzimidazol und ein anti-heliobactermittel enthalten zur behandlung von magen-darm krankheiten
ATE72120T1 (de) Verwendung von petasites-extrakten zur herstellung eines arzneimittels zur behandlung von gastrointestinalen erkrankungen.
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
FR2658190B1 (fr) Esters d'aminoacides de l'hydroquinone, leur procede de preparation et compositions pharmaceutiques ou cosmetiques les contenant.